GINKGO BIOWORKS HOLDINGS, INC. (DNA) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | 21.65M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $21.65M | (m) |
| 2026-03-31 | (m) | $8.06M | (m) |
| 2025-12-31 | (m) | $-312.76M | (m) |
| 2025-09-30 | (m) | $-339.55M | (m) |
| 2025-06-30 | (m) | $231.29M | (m) |
| 2025-03-31 | (m) | (m) | (m) |
| 2024-12-31 | (m) | $-547.03M | (m) |
| 2024-09-30 | (m) | $-651.19M | (m) |
| 2024-06-30 | (m) | $-897.68M | (m) |
| 2023-12-31 | (m) | $-892.87M | (m) |
| 2023-09-30 | (m) | $-856.64M | (m) |
| 2023-06-30 | (m) | $-1.22B | (m) |
| 2023-03-31 | (m) | $-1.72B | (m) |
| 2022-12-31 | (m) | $-2.10B | (m) |
| 2022-09-30 | (m) | $-3.53B | (m) |
| 2022-06-30 | (m) | $-2.96B | (m) |
| 2022-03-31 | (m) | $-2.35B | (m) |
| 2021-12-31 | (m) | $-1.83B | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) |
| 2020-12-31 | (m) | $-126.61M | (m) |
| 2020-09-30 | (m) | (m) | (m) |
| 2019-12-31 | (m) | $-119.33M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.